Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp57 | Bone and Osteoporosis | ECE2018

Kinesiotherapy rehabilitation program to correct deep core stability muscle dysfunction in patients with osteoporotic vertebral fractures

Makarova Ekaterina , Marchenkova Larisa , Eryomushkin Michail

Objective: The study is aimed to estimate the effectiveness of kinesiotherapy based on deep core stability muscles training in the program of rehabilitation in patients with osteoporotic vertebral fractures (VF).Material and methods: Fourty-five patients (M-4, F-41) aged 43-81 (average age 62.75±12.5) with primary osteoporosis and at least one non-traumatic VF were included in the study. The rehabilitation program focused on training of deep core st...

ea0056p601 | Obesity | ECE2018

Influence of body weight loss on gait and stability function in patients with obesity

Vasileva Valeriia , Marchenkova Larisa , Eryomushkin Michail

Objective: In our research we studied changes of gait and balance parameters and falls frequency in obese patients during weight loss.Materials and methods: We examined 37 patients aged 23–69 years (average age 53.6±11.1 years) with BMI ≥35 kg/m2 (average BMI 40.9±9.3 kg/m2). All patients received recommendations to adhere hypocaloric diet and perform physical exercises in order to reduce body weight. We evaluat...

ea0041ep332 | Clinical case reports - Thyroid/Others | ECE2016

A novel clinical phenotype of acquired partial lipodystrophy associated with intensive childhood cytostatic treatment

Nijhoff Michiel , Corssmit Eleonora , Louwerens Marloes , Jazet Ingrid , Pereira Alberto

Context: Lipodystrophy is characterized by subcutaneous fat loss, fat maldistribution, and metabolic syndrome. We present a novel phenotype of partial acquired lipodystrophy, possibly associated with childhood chemotherapy.Case reports: Two adult female patients that had been exposed to intensive cytostatic treatment in childhood for leukemia and aplastic anemia, respectively, were referred for therapy resistant diabetes. Both patients had distinct parti...

ea0056gp113 | Diabetes Translational | ECE2018

Diazoxide pretreatment improves pancreatic islet survival in vitro and functionality in vivo

Nijhoff Michiel , Carlotti Francoise , Engelse Marten , de Koning Eelco

The efficacy of human islet transplantation is reduced by loss of islets directly after transplantation. Ischemia is likely to be an important contributing factor to the observed islet loss. Diazoxide inhibits insulin secretion by beta cells and has been shown to exhibit anti-apoptotic and anti-ischemic effects. We hypothesized that preincubation of human islets with diazoxide leads to improved islet survival and graft function.Methods: Isolated human pa...

ea0073aep790 | Late Breaking | ECE2021

Patients susceptible to an adrenal crisis show marked differences in urinary cortisol excretion and glucocorticoid sensitive pathways

Vulto Annet , van Faassen Martijn , Kerstens Michiel , van Beek Andre

BackgroundAdrenal crisis (AC) is a life threatening medical situation caused by an absolute or relative cortisol deficiency. A biological predisposition may be of importance, because some patients never experience an AC, whereas others are admitted repeatedly to the hospital for an AC. Differences in cortisol pharmacokinetics (PK) and/or pharmacodynamics (PD) may underlie this vulnerability.ObjectiveTo study ...

ea0047oc6 | Spotlight on Neuroendocrine tumours | Theranostics2016

DNA damage assay in blood lymphocytes in peptide receptor radionuclide therapy patients with personalised high activities

Eberlein Uta , Scherthan Harry , Werner Rudolph A , Lapa Constantin , Bluemel Christina , Peper Michel , Buck Andreas K , Port Matthias , Lassmann Michael

Objectives: Radiation induces DNA double strand breaks (DSBs) that can be visualized and enumerated as microscopic γ-H2AX and 53BP1 foci. This study analysed the dose- and time-dependency of the DNA damage in blood lymphocytes in patients after a personalised high-activity 177Lu-DOTATATE treatment.Methods: We investigated multiple blood samples of three patients up to 96 h after personalised high-activity peptide receptor radionuclid...

ea0073oc12.2 | Oral Communications 12: Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Improved glucose metabolism and decreased weight gain in leptin-resistant, IGFBP2-deficient, db/db mice induced by AZP-3404, a 9-amino acid analog of IGFBP2

Culler Michael D. , Milano Stéphane , Ovize Michel , Delale Thomas , van der Lelij Aart Jan , Clemmons David

Insulin-like growth factor binding protein-2 (IGFBP2) has been demonstrated to be a key mediator of the peripheral actions of leptin, and its deficiency is associated with impaired metabolic function. The metabolic activity of IGFBP2 can be localized to a unique heparin-binding domain (HBD-1) within its structure. AZP-3404 is a 9-amino acid analog of the IGFBP2 HBD-1 that has been demonstrated to increase glucose uptake by differentiated mouse myotubes in vitro, and to increas...

ea0081p245 | Late-Breaking | ECE2022

Recalculating renin and aldosterone to improve specificity in the diagnosis of primary aldosteronism

Doyle Luc , Okiro Julie , Sarwani Aysha , Troy Michael , Ansari Yousef , O′Donoghue Darragh , Lappin David , Mcevoy John , O'Shea Paula , Ferguson John , Conall Dennedy Michael

Rationale: The Aldosterone:Renin ratio (ARR) is commonly used for patients fulfilling screening criteria for primary hyperaldosteronism (PA), followed by confirmatory testing. Reference intervals for interpretation of the ARR vary in accordance with local population and assay 1. While ARR provides high sensitivity for PA, this is compromised by low specificity, further compounded by medication interference. However, additional variables may improve the specificity of ARR as a ...

ea0047oc14 | Spotlight on Neuroendocrine tumours | Theranostics2016

68Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors – a head-to-head comparison with DOTATOC and FDG PET/CT

Lassmann Michael , Werner Rudolf A. , Weich Alexander , Wester Hans-Juergen , Scheurlen Michael , Higuchi Takahiro , Samnick Samuel , Bluemel Christina , Rudelius Martina , Buck Andreas K. , Lapa Constantin , Herrmann Ken

Introduction: Diagnostic imaging of neuroendocrine tumors (NETs) is the domain of somatostatin receptor (SSTR) agonists as well as FDG PET/CT in dedifferentiated tumors. SSTR also serves as target for receptor directed peptide therapy. More recently, specific ligands targeting the chemokine receptor 4 (CXCR4) were introduced potentially offering an additional theranostic option in NETs. Here we evaluated the CXCR4 expression using 68Ga-Pentixafor PET/CT in NET patie...

ea0037oc3.5 | Calcium, vitamin D and bone | ECE2015

Three-year safety and efficacy data for recombinant human parathyroid hormone, rhPTH(1-84), in the treatment of adults with hypoparathyroidism: the RACE study

Clarke Bart L , Mannstadt Michael , Vokes Tamara J , Rothman Jeffrey , Warren Mark L , Denham Douglas S , Levine Michael A , Lagast Hjalmar , Bilezikian John P , Shoback Dolores M

Hypoparathyroidism is a rare endocrine deficiency due to inadequate amounts of parathyroid hormone (PTH) and is characterised by hypocalcaemia and hyperphosphataemia. Current management regimens with large amounts of oral calcium and active vitamin D do not adequately control mineral homeostasis and can lead to complications in many patients. The phase III REPLACE and RELAY clinical trials established the efficacy and safety of once-daily s.c. injection of r...